(Q39474756)

12 September 2017

In vitro activities of the glycylcycline GAR-936 against gram-positive bacteria (English)

1 reference

12 September 2017

gram-positive bacteria

0 references

author name string

Boucher HW

series ordinal

1

1 reference

12 September 2017

Wennersten CB

series ordinal

2

1 reference

12 September 2017

Eliopoulos GM

series ordinal

3

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 August 2000

1 reference

Antimicrobial Agents and Chemotherapy

12 September 2017

1 reference

12 September 2017

44

1 reference

12 September 2017

2225-2229

1 reference

12 September 2017

8

1 reference

In vitro and in vivo antibacterial activities of a novel glycylcycline, the 9-t-butylglycylamido derivative of minocycline (GAR-936).

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90048

In vitro activity of RP59500, an injectable streptogramin antibiotic, against vancomycin-resistant gram-positive organisms

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90048

In vitro activities of two glycylcyclines against gram-positive bacteria

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90048

Inhibition of protein synthesis occurring on tetracycline-resistant, TetM-protected ribosomes by a novel class of tetracyclines, the glycylcyclines

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90048

Antimicrobial-drug resistance

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90048

Vancomycin-resistant enterococci. Mechanism and clinical relevance

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90048

Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90048

Rapid dissemination of beta-lactamase-producing, aminoglycoside-resistant Enterococcus faecalis among patients and staff on an infant-toddler surgical ward.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90048

Reduction in the incidence of methicillin-resistant Staphylococcus aureus and ceftazidime-resistant Klebsiella pneumoniae following changes in a hospital antibiotic formulary

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90048

Nosocomial enterococci resistant to vancomycin--United States, 1989-1993.

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90048

In-vitro activity of Sch 29482 in comparison with other oral antibiotics.

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90048

Determinants of vancomycin use in adult intensive care units in 41 United States hospitals

21 August 2018

1 reference

12 December 2020

Problems with antimicrobial resistance in gram-positive cocci

1 reference

12 December 2020

Risk factors for hospital-acquired Staphylococcus aureus bacteremia

1 reference

12 December 2020

Vancomycin-resistant enterococci in intensive care units: high frequency of stool carriage during a non-outbreak period

1 reference

12 December 2020

10.1128/AAC.44.8.2225-2229.2000

Identifiers

DOI

1 reference

12 September 2017

1 reference

12 September 2017

1 reference